Lowering B-type natriuretic peptide levels and increasing cardiac function: the role of levosimendan in the treatment of heart failure
Objective In this study, we examined whether levosimendan could lower B-type natriuretic peptide (BNP) and improve cardiac function in patients with heart failure who have diuretic resistance and low ejection fraction. Methods We conducted a cohort study among 120 participants from September 2022 to...
Saved in:
Main Authors: | Jianfeng Meng, Ye Zuo |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-02-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605241311434 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of galectin-3 and brain natriuretic peptide levels on echocardiographic parameters of left heart chamber following coronary artery bypass grafting
by: Yulia A. Styazhkina, et al.
Published: (2024-12-01) -
Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension
by: Shameek Gayen, et al.
Published: (2025-02-01) -
Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients
by: Zhengwen Xu, et al.
Published: (2025-02-01) -
Undocumented immigrants and advanced heart failure therapies
by: Matthew Kogan, et al.
Published: (2025-02-01) -
Yiqi Fumai Lyophilized injection protects cardiac contractility in a rat model of heart failure with reduced ejection fraction by modulating SERCA2
by: Yongwei Nie, et al.
Published: (2025-02-01)